Dawidowicz A L, Fijałkowska A, Nestorowicz A, Kalityński R, Trojanowski T
Department of Chemical Physics and Physicochemical Separation Methods, Faculty of Chemistry, Maria Curie-Skłodowska University, 20-031 Lublin, pl. Marii Curie-Skłodowskiej 3, Poland.
Br J Anaesth. 2003 Jan;90(1):84-6.
The aim of this paper is to compare the propofol concentration in blood and cerebrospinal fluid (CSF) in patients scheduled for different neurosurgical procedures and anaesthetized using propofol as part of a total intravenous anaesthesia technique.
Thirty-nine patients (ASA I-III) scheduled for elective intracranial procedures, were studied. Propofol was infused initially at 12 mg kg(-1) h(-1) and then reduced in steps to 9 and 6 mg kg(-1) h(-1). During anaesthesia, bolus doses of fentanyl and cis-atracurium were administered as necessary. After tracheal intubation the lungs were ventilated to achieve normocapnia with an oxygen-air mixture (FI(O(2))=0.33). Arterial blood and CSF samples for propofol examination were obtained simultaneously directly after intracranial drainage insertion and measured using high-performance liquid chromatography. The patients were divided into two groups depending on the type of neurosurgery. The Aneurysm group consisted of 13 patients who were surgically treated for ruptured intracranial aneurysm. The Tumour group was composed of 26 patients who were undergoing elective posterior fossa extra-axial tumour removal.
Blood propofol concentrations in both groups did not differ significantly (P>0.05). The propofol concentration in CSF was 86.62 (SD 37.99) ng ml(-1) in the Aneurysm group and 50.81 (26.10) ng ml(-1) in the Tumour group (P<0.005).
Intracranial pathology may influence CSF propofol concentration. However, the observed discrepancies may also result from quantitative differences in CSF composition and from restricted diffusion of the drug in the CSF.
本文旨在比较计划接受不同神经外科手术并使用丙泊酚作为全静脉麻醉技术一部分进行麻醉的患者血液和脑脊液(CSF)中的丙泊酚浓度。
对39例计划进行择期颅内手术的患者(ASA I - III级)进行研究。丙泊酚初始输注速度为12 mg·kg⁻¹·h⁻¹,然后逐步降至9和6 mg·kg⁻¹·h⁻¹。麻醉期间,根据需要给予芬太尼和顺式阿曲库铵推注剂量。气管插管后,用氧气 - 空气混合物(Fi(O₂)=0.33)进行肺通气以维持正常碳酸血症。在颅内引流管插入后立即同时采集动脉血和脑脊液样本用于丙泊酚检测,并使用高效液相色谱法进行测量。根据神经外科手术类型将患者分为两组。动脉瘤组由13例接受颅内动脉瘤破裂手术治疗的患者组成。肿瘤组由26例接受择期后颅窝轴外肿瘤切除术的患者组成。
两组患者的血液丙泊酚浓度无显著差异(P>0.05)。动脉瘤组脑脊液中的丙泊酚浓度为86.62(标准差37.99)ng/ml,肿瘤组为50.81(26.10)ng/ml(P<0.005)。
颅内病变可能影响脑脊液中丙泊酚的浓度。然而,观察到的差异也可能是由于脑脊液成分的定量差异以及药物在脑脊液中的扩散受限所致。